Search clinical trials for: SFA stent

Total 3880 results

Meshalkin Research Institute of Pathology of Circulation

Recruiting

Efficacy and Safety Comparison of the Endovascular and the Hybrid Methods for the Treatment of Prolonged Atherosclerotic Lesions of the Femoral-popliteal Segment Above the Knee, TASC II, Type D

Atherosclerosis | Ischemia Limb | Superficial Femoral Artery Occlusion | Popliteal Artery Occlusion | Stent Complication

Russian Federation
Meshalkin Research Institute of Pathology of Circulation

Recruiting

Efficacy and Safety Comparison of the Open Surgical and Endovascular Methods for the Treatment of Long Atherosclerotic Lesions of the Femoral-popliteal Segment Above the Knee, TASC II, Type D.

Atherosclerosis | Ischemia Limb | Superficial Femoral Artery Occlusion | Popliteal Artery Occlusion

Russian Federation
Kuopio University Hospital
Turku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaborators

Recruiting

Paclitaxel Eluting Stent in Long SFA Obstruction: A Prospective, Randomized Comparison With Bypass Surgery (finnptx)

Claudication | Chronic Lower Limb Ischemia | Critical Ischemia | Peripheral Athero Obstructive Disease

Finland
InnoRa GmbH
Boston Scientific Corporation; B. Braun Melsungen AG

Completed

Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions (SPORTS)

Restenosis | Occlusion | Stenosis

Austria, Germany
University of Leipzig

Active, not recruiting

BEST SFA Pilot Study - Best Endovascular STrategy for Complex Lesions of the Superficial Femoral Artery

Peripheral Arterial Disease

Germany
Medinol Ltd.

Terminated

ChampioNIR® SFA Stent EFS Study

Peripheral Arterial Disease

Israel
University of Nebraska
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Terminated

Optimal Stent Selection for the Femoropopliteal Artery (SFA)

Femoropopliteal Stenting

United States
Terumo Europe N.V.

Active, not recruiting

Prospective Multicenter Study to Confirm the Performance of the Renzan Stent in Treatment of SFA/POP Artery Disease (PRIZER)

Superficial Femoral Artery Disease | Popliteal Artery Disease

Spain, Belgium, Germany, France, Netherlands
Boston Scientific Corporation

Completed

ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent (IMPERIAL)

Atherosclerosis of Native Arteries of the Extremities

New Zealand, United States, Belgium, Canada, Japan, Germany, Austria
Boston Scientific Corporation

Completed

A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries (REGAL)

Vascular Diseases | Arteriosclerosis | Arterial Occlusive Diseases | Atherosclerosis

Spain, Austria, Belgium, Italy, France
Veryan Medical Ltd.

Active, not recruiting

MIMICS-3D-USA Registry Study

Peripheral Arterial Disease

United States
be Medical
Universitaire Ziekenhuizen KU Leuven; Ziekenhuis Oost-Limburg

Completed

Belgian Prospective Multicentre Registry to Evaluate Safety and Performance of the Optimed Stent in the Superficial Femoral Artery (BOSS)

Peripheral Arterial Disease

Belgium
Boston Scientific Corporation

Active, not recruiting

Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery (EMINENT)

Vascular Diseases | Arteriosclerosis | Arterial Occlusive Diseases | Atherosclerosis

Germany, Ireland, Belgium, United Kingdom, France, Switzerland, Spain, Austria, Italy, Netherlands
Rijnstate Hospital

Completed

Blood Flow Quantification Near Stented SFA Lesions Using Ultrasound Velocimetry (EchoPIV in SFA)

Peripheral Arterial Disease

Netherlands
Veryan Medical Ltd.
Massachusetts General Hospital; ClinLogix. LLC; Yale Cardiovascular Research...

Completed

Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System (MIMICS-2)

Peripheral Arterial Disease

United States, Japan, Germany
Assiut University

Unknown

Predictors of Coronary Revascularization Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome

Diabetes Mellitus, Type 2 With Acute Coronary Syndrom
C. R. Bard

Terminated

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM") (CONTINUUM)

Superficial Femoral Artery Stenosis

United States
Veryan Medical Ltd.

Unknown

Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D (MIMICS-3D)

Peripheral Arterial Disease

Netherlands, Sweden, Germany, Belgium
Arkansas Heart Hospital

Completed

Drug Eluting Stent for the Management of PERipheral Arterial Disease Of the SFA (DESPERADO-SFA Study) (DESPERADO)

Peripheral Arterial Disease

United States
C. R. Bard

Completed

Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis (SFA ISR)

Restenosis | Femoral Artery Occlusion | Femoral Artery Stenosis

United States
Boston Scientific Corporation

Completed

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project (MAJESTIC)

Atherosclerosis of Native Arteries of the Extremities

New Zealand, Germany, Belgium, Australia, Austria
Medtronic Endovascular

Completed

Safety and Effectiveness Study of EverFlex Stent to Treat Symptomatic Femoral-popliteal Atherosclerosis (DURABILITY II)

Peripheral Vascular Diseases | Claudication
University Hospital, Essen

Unknown

SFA TReatment and vAscular Functions (STRAtiFy)

Peripheral Arterial Disease | Claudication, Intermittent

Germany
be Medical

Completed

Endovascular Treatment of Atherosclerotic Lesions in the SFA Using the Sinus-superflex-635 Stent

Atherosclerotic Heart Disease

Belgium
Catharina Ziekenhuis Eindhoven

Terminated

Short Spot Versus Long Lesion Stenting as Best Treatment for Extensive Occlusive SFA Disease (STRONG)

Peripheral Arterial Disease
Johns Hopkins University

Completed

Revascularization With Open Bypass Versus Angioplasty and STenting of the Lower Extremity Trial (ROBUST) (ROBUST)

Superficial Femoral Artery Occlusion | Claudication | Superficial Femoral Artery Stenosis | Rest Pain

United States
North Texas Veterans Healthcare System

Terminated

Excellence in Peripheral Arterial Disease Treatment of Superficial Femoral Artery Disease With Drug-eluting Stents (XLPAD DES SFA)

Peripheral Vascular Diseases | Chronic Total Occlusion of Artery of the Extremities

United States
Cordis Corporation
Massachusetts General Hospital; Prairie Education and Research Cooperative

Completed

Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System (OPEN)

Cardiovascular Diseases | Peripheral Vascular Disease | Peripheral Artery Disease | Vascular Disease | PAD

United States, Belgium
Terumo Medical Corporation
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; ClinLogix...

Completed

A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery (OSPREY)

Peripheral Vascular Disease

United States
W.L.Gore & Associates

Completed

Evaluation of the GORE TIGRIS Vascular Stent (TIGRIS)

Peripheral Arterial Disease

United States
Lund University

Completed

Primary Stenting vs Conservative Treatment in Claudicants - a Study on Quality of Life

Best Medical Treatment | Superficial Femoral Artery Disease | Stable Claudication (Fontaine IIa and IIb) | Quality of Life Scores at 12 and 24 Months

Sweden
C. R. Bard
CardioVascular Research Foundation, Korea

Completed

Edwards Lifesciences Self-Expanding Stent Peripheral Vascular Disease Study (RESILIENT)

Intermittent Claudication | Arterial Occlusive Disease | Atherosclerotic Disease
Abbott Medical Devices
Baim Institute for Clinical Research

Completed

Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery (SUPERB)

Peripheral Vascular Disease

United States
Boston Scientific Corporation

Completed

SuperNOVA Clinical Stenting Trial

Atherosclerosis of Native Arteries of the Extremities, Unspecified

Belgium, United States, United Kingdom, Japan, Austria, Canada, Germany
C. R. Bard

Completed

A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY) (REALITY)

Peripheral Artery Disease

Germany
Meshalkin Research Institute of Pathology of Circulation

Unknown

Pilot Prospective Study of Two Methods of Revascularization of the Femoral Artery (SFA): Stenting in the SFA, and Stenting of the SFA, Supplemented by Fasciotomy in Hunter Channel.

Atherosclerosis of the Peripheral Artery

Russian Federation
Yonsei University

Completed

Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension

Korea, Republic of
Nantes University Hospital

Completed

PacLitaxel Eluting Balloon Application In Sfa In Stent Restenosis (PLAISIR)

Peripheral Arterial Disease

France
Medtronic Endovascular

Completed

The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions

Peripheral Vascular Disease

United States
W.L.Gore & Associates

Completed

Evaluation of the 25 Centimeter (cm) GORE® VIABAHN® Endoprosthesis

Peripheral Vascular Diseases
University Health Network, Toronto

Unknown

Paclitaxel Eluting Balloon for SFA In-stent Restenosis

In-stent Arterial Restenosis

Canada
Spectranetics Corporation
Yale University

Withdrawn

First in Human Study of Winsor Laser Catheter: A Prospective Registry to Evaluate The Safety and Performance of the Winsor Laser Catheter in the Treatment of In-Stent Restenosis

Femoropopliteal In-Stent Restenosis

Colombia
Flanders Medical Research Program

Completed

GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Restenosis (RELINE)

Peripheral Vascular Disease

Belgium, Germany
Provascular GmbH
Boston Scientific Corporation

Completed

Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent (SUMMIT)

Peripheral Arterial Diseases | Superficial Femoral Artery Stenosis

Germany
Endovascular Consultoria Limitada
Boston Scientific Corporation; Angiolog Consultoria Ltda

Completed

Efficacy of the EPIC Nitinol Vascular Stent System in Superficial Femoral Artery (SFA) Lesions (EPIC SFA BR)

Superficial Femoral Artery Stenosis | Atherosclerosis of Femoral Artery

Brazil
North Texas Veterans Healthcare System
Boston Scientific Corporation

Completed

Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease (COBRA)

PERIPHERAL VASCULAR DISEASE

United States
Flanders Medical Research Program
Medtronic Neurovascular Clinical Affairs

Completed

DURABILITY+ : a Prospective, Multi-center, Controlled Study With the Everflex+ Stent in SFA Lesions (DURABILITY+)

Peripheral Arterial Disease

Belgium
Fundacja Ośrodek Badań Medycznych

Completed

Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction (CORAMIreg)

Myocardial Infarction

Poland, Slovenia
Leonardo Bolognese, MD

Completed

Drug Eluting Balloon in peripherAl inTErvention SFA (DEBATE SFA)

Peripheral Arterial Disease

Italy
Prof. Dr. med. Gunnar Tepe
Zeller; Duda; Albrecht; Reimer; Brechtel; Diehm; Strausinsky; Jahnke; Huppert; Amendt

Unknown

Cotavance™ Paclitaxel-Coated Balloon Versus Uncoated Balloon Angioplasty for Treatment of In-stent Restenosis in SFA and Popliteal Arteries

Catherization

Germany

Search clinical trials for: SFA stent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations